DE60214414D1 - Peptidderivat, pharmazeutisch unbedenkliches salz davon, verfahren zu dessen herstellung und dessen verwendung - Google Patents

Peptidderivat, pharmazeutisch unbedenkliches salz davon, verfahren zu dessen herstellung und dessen verwendung

Info

Publication number
DE60214414D1
DE60214414D1 DE60214414T DE60214414T DE60214414D1 DE 60214414 D1 DE60214414 D1 DE 60214414D1 DE 60214414 T DE60214414 T DE 60214414T DE 60214414 T DE60214414 T DE 60214414T DE 60214414 D1 DE60214414 D1 DE 60214414D1
Authority
DE
Germany
Prior art keywords
group
peptide derivative
substantial
production
pharmaceutically salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60214414T
Other languages
English (en)
Other versions
DE60214414T2 (de
Inventor
Kenji Yamamoto
Yoshimitsu Suda
Tetsuji Asao
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kyushu University NUC
Original Assignee
Taiho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taiho Pharmaceutical Co Ltd filed Critical Taiho Pharmaceutical Co Ltd
Application granted granted Critical
Publication of DE60214414D1 publication Critical patent/DE60214414D1/de
Publication of DE60214414T2 publication Critical patent/DE60214414T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/30Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to nitro or nitroso groups
    • C07C279/32N-nitroguanidines
    • C07C279/36Substituted N-nitroguanidines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE60214414T 2001-11-16 2002-11-14 Peptidderivat, pharmazeutisch verträgliches salz davon, verfahren zu dessen herstellung und dessen verwendung Expired - Lifetime DE60214414T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2001352012 2001-11-16
JP2001352012 2001-11-16
PCT/JP2002/011860 WO2003042237A1 (fr) 2001-11-16 2002-11-14 Derive peptidique, sel pharmaceutiquement acceptable de celui-ci, procede de production et utilisation dudit derive

Publications (2)

Publication Number Publication Date
DE60214414D1 true DE60214414D1 (de) 2006-10-12
DE60214414T2 DE60214414T2 (de) 2007-02-22

Family

ID=19164244

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60214414T Expired - Lifetime DE60214414T2 (de) 2001-11-16 2002-11-14 Peptidderivat, pharmazeutisch verträgliches salz davon, verfahren zu dessen herstellung und dessen verwendung

Country Status (10)

Country Link
US (1) US7067476B2 (de)
EP (1) EP1445262B1 (de)
JP (1) JP4006598B2 (de)
KR (1) KR100603948B1 (de)
CN (1) CN1274712C (de)
AT (1) ATE338057T1 (de)
AU (1) AU2002343783B2 (de)
CA (1) CA2465080A1 (de)
DE (1) DE60214414T2 (de)
WO (1) WO2003042237A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101260086B (zh) * 2007-03-06 2011-08-10 中国科学院上海药物研究所 蛋白酪氨酸磷酸酯酶1b抑制剂及其制备方法和用途
JP5397851B2 (ja) * 2009-05-21 2014-01-22 Nsマテリアルズ株式会社 ペプチド誘導体又はその塩の製造方法
WO2017201322A1 (en) * 2016-05-19 2017-11-23 Cortexyme, Inc. Treatment of osteoarthritis with gingipain blocking agents

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0597708A (ja) 1991-10-02 1993-04-20 Lion Corp 歯周病治療剤
JPH11139947A (ja) 1997-11-11 1999-05-25 Sunstar Inc マトリックスメタロプロテアーゼ阻害剤含有口腔用組成物
JP3873429B2 (ja) * 1998-02-20 2007-01-24 大鵬薬品工業株式会社 ペプチド誘導体及びその薬学的に許容される塩、その製造方法及びその用途
JPH11335274A (ja) 1998-03-20 1999-12-07 Sagami Chem Res Center アルギンギパイン阻害剤、歯周病菌生育阻害剤および抗歯周病剤
JP2000191487A (ja) 1998-12-29 2000-07-11 Sunstar Inc マトリクスメタロプロテア―ゼ阻害用口腔剤組成物及び飲食品組成物
WO2002036551A1 (fr) * 2000-11-06 2002-05-10 Taiho Pharmaceutical Co., Ltd. Derives peptidiques et sels pharmaceutiquement acceptables de ceux-ci, procedes de preparation et d'utilisation associes

Also Published As

Publication number Publication date
KR100603948B1 (ko) 2006-07-24
EP1445262A4 (de) 2005-06-15
EP1445262A8 (de) 2004-10-27
US20040214780A1 (en) 2004-10-28
CN1622953A (zh) 2005-06-01
EP1445262B1 (de) 2006-08-30
US7067476B2 (en) 2006-06-27
DE60214414T2 (de) 2007-02-22
CN1274712C (zh) 2006-09-13
WO2003042237A1 (fr) 2003-05-22
JP4006598B2 (ja) 2007-11-14
ATE338057T1 (de) 2006-09-15
CA2465080A1 (en) 2003-05-22
EP1445262A1 (de) 2004-08-11
AU2002343783B2 (en) 2007-01-18
KR20050044448A (ko) 2005-05-12
JPWO2003042237A1 (ja) 2005-03-10

Similar Documents

Publication Publication Date Title
AU699008B2 (en) Aminothiazole derivative, medicament containing the same, and intermediate for preperation of said compound
IL148014A0 (en) Cell adhesion inhibitors
EP0976748A4 (de) Pyrrolidin-derivate die eine phospholipase-a2-hemmende wirkung haben
AU3599701A (en) Fluorescent probes for the quantitation of zinc
EP1362844A4 (de) Benzylaminanalogon
ATE239741T1 (de) Derivate der phosphonsäure zur inhibierung von carboxypeptidase b
DE69901627D1 (de) Verfahren zur Herstellug von 3-Amino-pyrrolidinderivaten
DE60214414D1 (de) Peptidderivat, pharmazeutisch unbedenkliches salz davon, verfahren zu dessen herstellung und dessen verwendung
ATE376830T1 (de) Benzo(b(thiophenderivate und verfahren zu deren herstellung
WO2001072688A3 (fr) Procede de preparation de la (2s,3r,4s)-4-hydroxyisoleucine et de ses analogues
AU655869B2 (en) An amphoteric tricyclic compound
ATE289992T1 (de) Geschützte tyrosinderivate, verfahren zu deren herstellung und deren verwendung zur herstellung von o-(2- ?18 f)-fluorethyl)-l-tyrosin
ATE420067T1 (de) Peptid-derivate und ihre pharmazeutisch akzeptablensalze, verfahren zur herstellung von beiden und ihre verwendung
AU2002244985A1 (en) Thiazolidinedione derivatives and pharmaceutical composition comprising the same
EP1005334A4 (de) Nervenschützende verbindungen und ihre verwendungen
WO2004089962A3 (en) New carbamoyl-and thiocarbamoyl-phosphonates and pharmaceutical compositions comprising them
ES2149180T3 (es) Derivado de pirazolotiazolopirimidina.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORA, JP